Thor Goodfellow
Internal Medicine · Jackson, MSNPI 1376005850
Payments from drug & device makers
Across 101 payments — averaging $24.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$177
- Novartis$167
- Abbott$156
- Merck$155
- Johnson & Johnson$138
- E.r. Squibb & Sons, L.L.C.$131
- plus $2K from 24 others
What the payments were for
- Food & beverage$2,29994%
- Education$1376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $177 |
| Novartis | 10 | $167 |
| Abbott | 2 | $156 |
| Merck | 8 | $155 |
| Johnson & Johnson | 7 | $138 |
| E.r. Squibb & Sons, L.L.C. | 8 | $131 |
| Abiomed | 1 | $125 |
| Boston Scientific | 4 | $124 |
| Heartflow, Inc. | 1 | $121 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| Procyrion, Inc. | 3 | $99 |
| AstraZeneca | 6 | $98 |
| Boehringer Ingelheim | 6 | $97 |
| Coherus Oncology, Inc. | 1 | $95 |
| Amgen | 1 | $91 |
| Inspire Medical Systems, Inc. | 4 | $87 |
| United Therapeutics Corporation | 3 | $81 |
| Alnylam Pharmaceuticals Inc. | 5 | $75 |
| Bridgebio Pharma, Inc. | 3 | $61 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Novo Nordisk | 2 | $31 |
| Chiesi USA, Inc. | 2 | $30 |
| Livanova USA, Inc. | 1 | $25 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| GE HealthCare | 1 | $19 |
| Medtronic | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Merge Healthcare Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,436 in reported general payments places this provider in the 75th percentile of 846 internal medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $7,791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $97 | $7,79112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Jackson
- Bob HutchinsJackson$4.6M
- Sarah KerutJackson$319K
- Gabriel HernandezJackson$196K
- Kelly WilkinsonJackson$183K
- Christina BarlowJackson$129K
- Carrie WynnJackson$69K
- Shanna PettieJackson$53K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
- James WilliamsJackson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.